At this point in time, we are all pretty familiar with Botox® - the injectable treatment used to soften lines of the face. Most people even know Botox® can be used for a multitude of medicinal reasons, including excessive sweating and migraines. However, a few new applications for Botox® injections have popped up recently. Keep…
Last week, Merz Pharmaceuticals announced the FDA approval of a new challenger to Botox®, Xeomin®. Xeomin, which contains botulinum toxin type A, was approved for treatment of cervical dystonia (neck spasms) and blepharospasm (eye spasms). To date, Dysport® has been the only competitor to Botox®, however, Xeomin® may be the new competition. Xeomin® is similar…